- Home
- QFIN vs ACLX Comparison
QFIN vs ACLX Comparison
Compare QFIN & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QFIN
- ACLX
- Stock Information
- Founded
- QFIN 2016
- ACLX 2015
- Country
- QFIN China
- ACLX United States
- Employees
- QFIN 3527
- ACLX N/A
- Industry
- QFIN Finance: Consumer Services
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- QFIN Finance
- ACLX Health Care
- Exchange
- QFIN Nasdaq
- ACLX Nasdaq
- Market Cap
- QFIN 4.0B
- ACLX 4.4B
- IPO Year
- QFIN 2018
- ACLX 2022
- Fundamental
- Price
- QFIN $28.53
- ACLX $87.26
- Analyst Decision
- QFIN Strong Buy
- ACLX Strong Buy
- Analyst Count
- QFIN 2
- ACLX 12
- Target Price
- QFIN $45.10
- ACLX $114.75
- AVG Volume (30 Days)
- QFIN 1.8M
- ACLX 515.6K
- Earning Date
- QFIN 11-18-2025
- ACLX 11-06-2025
- Dividend Yield
- QFIN 5.38%
- ACLX N/A
- EPS Growth
- QFIN 68.82
- ACLX N/A
- EPS
- QFIN 7.06
- ACLX N/A
- Revenue
- QFIN $2,618,582,596.00
- ACLX $56,979,000.00
- Revenue This Year
- QFIN $17.67
- ACLX N/A
- Revenue Next Year
- QFIN $6.25
- ACLX $210.71
- P/E Ratio
- QFIN $4.29
- ACLX N/A
- Revenue Growth
- QFIN 9.77
- ACLX N/A
- 52 Week Low
- QFIN $27.64
- ACLX $47.86
- 52 Week High
- QFIN $48.94
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- QFIN 44.09
- ACLX 68.46
- Support Level
- QFIN $28.29
- ACLX $83.33
- Resistance Level
- QFIN $31.08
- ACLX $89.31
- Average True Range (ATR)
- QFIN 1.29
- ACLX 2.66
- MACD
- QFIN 0.04
- ACLX 0.42
- Stochastic Oscillator
- QFIN 15.00
- ACLX 63.77
About QFIN Qifu Technology Inc.
Qfin Holdings Inc Formerly Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.